Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-066147
Filing Date
2014-11-07
Accepted
2014-11-07 17:21:45
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v392754_10q.htm 10-Q 485860
2 EXHIBIT 31.1 v392754_ex31-1.htm EX-31.1 8266
3 EXHIBIT 31.2 v392754_ex31-2.htm EX-31.2 8325
4 EXHIBIT 32.1 v392754_ex32-1.htm EX-32.1 3516
5 EXHIBIT 32.2 v392754_ex32-2.htm EX-32.2 3665
  Complete submission text file 0001144204-14-066147.txt   8483100

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ambs-20140930.xml EX-101.INS 1484975
7 XBRL TAXONOMY EXTENSION SCHEMA ambs-20140930.xsd EX-101.SCH 98206
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ambs-20140930_cal.xml EX-101.CAL 37827
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ambs-20140930_def.xml EX-101.DEF 495638
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ambs-20140930_lab.xml EX-101.LAB 501812
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ambs-20140930_pre.xml EX-101.PRE 546910
Mailing Address C/O JANSSEN LABS @ QB3 953 INDIANA STREET SAN FRANCISCO CA 94107
Business Address C/O JANSSEN LABS @ QB3 953 INDIANA STREET SAN FRANCISCO CA 94107 (408) 737-2734
Amarantus Bioscience Holdings, Inc. (Filer) CIK: 0001424812 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55016 | Film No.: 141205924
SIC: 2834 Pharmaceutical Preparations